{"log_id": 3977072421051464149, "direction": 0, "words_result_num": 50, "words_result": [{"probability": {"variance": 0.000413, "average": 0.981412, "min": 0.943695}, "location": {"width": 88, "top": 34, "height": 19, "left": 35}, "words": "【药理毒理"}, {"probability": {"variance": 2.5e-05, "average": 0.996169, "min": 0.98745}, "location": {"width": 66, "top": 58, "height": 18, "left": 45}, "words": "药理作用"}, {"probability": {"variance": 0.025445, "average": 0.91188, "min": 0.480923}, "location": {"width": 696, "top": 79, "height": 30, "left": 69}, "words": "本品为非镇静性的长效兰环类抗组胺药,是氯雷他定的活性代谢物,可通过选择性拮抗外周耳受"}, {"probability": {"variance": 0.013107, "average": 0.96208, "min": 0.389}, "location": {"width": 721, "top": 102, "height": 29, "left": 45}, "words": "体,缓解过敏性鼻炎或慢性特发性荨麻疹的相关症状。另外,体外研究结果,本品可制组胺从人肥大"}, {"probability": {"variance": 0.002763, "average": 0.984951, "min": 0.745427}, "location": {"width": 354, "top": 126, "height": 20, "left": 45}, "words": "细胞释放。动物研究提示,本品不易通过血脑屏障"}, {"probability": {"variance": 0.00048, "average": 0.985884, "min": 0.948057}, "location": {"width": 66, "top": 148, "height": 18, "left": 53}, "words": "毒理研究"}, {"probability": {"variance": 0.004225, "average": 0.971942, "min": 0.591974}, "location": {"width": 680, "top": 170, "height": 29, "left": 85}, "words": "急性毒性:大鼠经口给药剂量达250mg/kg时出现死亡(按AUC计算,地氯雷他定及其代谢产物的"}, {"probability": {"variance": 0.00677, "average": 0.966579, "min": 0.555569}, "location": {"width": 721, "top": 192, "height": 30, "left": 44}, "words": "暴露量约为临床推荐日口服剂量的120倍),小鼠经口给药LD0为353mg/kg(按体表面积计算,地氯雷"}, {"probability": {"variance": 0.003193, "average": 0.97479, "min": 0.726508}, "location": {"width": 721, "top": 215, "height": 29, "left": 42}, "words": "他定约为临床推荐剂量的290倍)。猴经口给药剂量达250mg/kg按体表面积计算,地氯雷他定约为临床"}, {"probability": {"variance": 0.001038, "average": 0.985935, "min": 0.865675}, "location": {"width": 247, "top": 239, "height": 19, "left": 44}, "words": "推荐剂量的810倍时,未出现死亡"}, {"probability": {"variance": 0.002314, "average": 0.975823, "min": 0.770083}, "location": {"width": 680, "top": 261, "height": 27, "left": 84}, "words": "遗传毒性:在回复突变试验(沙门/大肠埃希菌、哺乳动物微粒体基因突变试验)和染色体畸变试"}, {"probability": {"variance": 0.023529, "average": 0.933445, "min": 0.399336}, "location": {"width": 589, "top": 283, "height": 26, "left": 43}, "words": "验(人外周血淋巴细胞诱裂性试验和小鼠骨髓微核试验)中,见本品有潜在遗传毒性"}, {"probability": {"variance": 0.04201, "average": 0.865377, "min": 0.512017}, "location": {"width": 66, "top": 307, "height": 16, "left": 75}, "words": "生殖毒性"}, {"probability": {"variance": 0.008962, "average": 0.953183, "min": 0.528446}, "location": {"width": 688, "top": 327, "height": 28, "left": 75}, "words": "本品经口给药剂量达24mg/kg/日(地氯雷他定及其代谢物的暴露量约为临床日推荐口服剂量下AUC"}, {"probability": {"variance": 0.006473, "average": 0.962364, "min": 0.576526}, "location": {"width": 722, "top": 350, "height": 28, "left": 42}, "words": "的130倍)时,对雌性大鼠生育力无影响;经口给药剂量达12mg/kg地雷他定的桑露量约为临床日推荐"}, {"probability": {"variance": 0.003831, "average": 0.982963, "min": 0.591612}, "location": {"width": 720, "top": 372, "height": 28, "left": 43}, "words": "口服剂量下AUC的45倍)时,出现雌鼠受孕率下降、雄鼠精子数减少、精子活力降低和丸组织学改"}, {"probability": {"variance": 0.007857, "average": 0.968386, "min": 0.517619}, "location": {"width": 719, "top": 394, "height": 30, "left": 42}, "words": "变,表明雄性大鼠生育力降低;经口给药剂量为3mg/kg/日地氯雷他定及其代谢物的暴露量约为临床日"}, {"probability": {"variance": 0.00021, "average": 0.993114, "min": 0.933328}, "location": {"width": 396, "top": 418, "height": 22, "left": 42}, "words": "推荐口服剂下AUC的8倍)时,对大鼠生育力无影响"}, {"probability": {"variance": 0.006551, "average": 0.967411, "min": 0.65432}, "location": {"width": 678, "top": 439, "height": 29, "left": 82}, "words": "大鼠和家兔经口给予本品,剂册分别达48和60mg/kg日(地氯雷他定及其代谢物的暴露量分别约"}, {"probability": {"variance": 0.015366, "average": 0.949346, "min": 0.445974}, "location": {"width": 722, "top": 462, "height": 30, "left": 41}, "words": "为临床日推荐口根剂量下AUC的210和230倍)时,未见致略作用。雌性大鼠给药剂量为24mg/kg(地"}, {"probability": {"variance": 0.005178, "average": 0.971901, "min": 0.602981}, "location": {"width": 713, "top": 484, "height": 28, "left": 41}, "words": "氯雷他定及其代谢物的暴量约为临床日推荐口服剂量下AUC的120倍)时,可见植入前丢失率增加"}, {"probability": {"variance": 0.003519, "average": 0.972568, "min": 0.758342}, "location": {"width": 721, "top": 507, "height": 27, "left": 41}, "words": "植入数和胚胎数减少;给药剂量为9mg/kg日(地氯雷他定及其代谢物的暴露约为临床日推荐口服剂"}, {"probability": {"variance": 0.003876, "average": 0.966858, "min": 0.729907}, "location": {"width": 721, "top": 528, "height": 30, "left": 40}, "words": "下AUC的50倍)或以上时,可见仔鼠体重减轻和翻正反射减慢;给药剂量为3mg/kg/日(地雷他定及"}, {"probability": {"variance": 0.004871, "average": 0.969116, "min": 0.713256}, "location": {"width": 621, "top": 551, "height": 27, "left": 39}, "words": "其代谢物的暴露量约为临床日推荐口服剂下AUC的7倍)时,本品对仔鼠发育无影响"}, {"probability": {"variance": 0.008347, "average": 0.968239, "min": 0.48695}, "location": {"width": 688, "top": 574, "height": 27, "left": 71}, "words": "致癌性:通过氯雷他定的研究对本品的潜在致癌性进行了评估。小鼠和大鼠分别连续经口给予雷"}, {"probability": {"variance": 0.003983, "average": 0.974862, "min": 0.687165}, "location": {"width": 730, "top": 596, "height": 28, "left": 31}, "words": "他定18个月和2年,雄性小鼠给药剂量达40mgkg日(地氯雷他定及其代谢物的暴露约为临床日推荐"}, {"probability": {"variance": 0.026559, "average": 0.913155, "min": 0.415988}, "location": {"width": 728, "top": 618, "height": 29, "left": 32}, "words": "口服剂量下AUC的3倍》时,肝细胞(包括腺瘤和癌)的发生明显高于对照组。雄性大鼠给药剂量为"}, {"probability": {"variance": 0.008173, "average": 0.970691, "min": 0.378264}, "location": {"width": 729, "top": 641, "height": 26, "left": 31}, "words": "10mg/kg日,雌性和雄性大鼠给药剂量为25mg/kg日(地氯雷他定及其代谢物的暴露分别约为临床日推"}, {"probability": {"variance": 0.012779, "average": 0.951082, "min": 0.42856}, "location": {"width": 731, "top": 660, "height": 30, "left": 30}, "words": "荐口服剂量下AUC的7和30倍)时,肝细胞瘤发生率显著升高。以上发现与地他定长期给药的临床"}, {"probability": {"variance": 0.000162, "average": 0.992467, "min": 0.962246}, "location": {"width": 115, "top": 685, "height": 18, "left": 31}, "words": "相关性尚不明确"}, {"probability": {"variance": 0.000497, "average": 0.989221, "min": 0.934672}, "location": {"width": 104, "top": 707, "height": 18, "left": 27}, "words": "【药代动力学】"}, {"probability": {"variance": 0.000617, "average": 0.987047, "min": 0.897052}, "location": {"width": 686, "top": 729, "height": 28, "left": 73}, "words": "文献报导,地氯雷他定口服后30分钟可测得其血浆浓度,约3小时后可被良好吸收并达最高血药"}, {"probability": {"variance": 0.020002, "average": 0.942409, "min": 0.474376}, "location": {"width": 720, "top": 751, "height": 28, "left": 39}, "words": "浓度、其消除半衰期约为27小时。地氯雷他定的蓄积程度与其半衰期(约27小时)及每日一次的服药间"}, {"probability": {"variance": 0.009866, "average": 0.96043, "min": 0.442424}, "location": {"width": 522, "top": 773, "height": 27, "left": 41}, "words": "隔一致。地氯他定的血药浓度及AUC在5mg-20rg范围内与剂量成正比"}, {"probability": {"variance": 0.011818, "average": 0.951904, "min": 0.458764}, "location": {"width": 690, "top": 795, "height": 30, "left": 70}, "words": "地氯雷他定可与血浆蛋白中等程度结合(83%~87%)。每日1次口服5mg20mg连服14天,无证"}, {"probability": {"variance": 0.011254, "average": 0.970015, "min": 0.546096}, "location": {"width": 275, "top": 817, "height": 20, "left": 36}, "words": "据表明存在有临床相关意义的药物蓄积"}, {"probability": {"variance": 0.009413, "average": 0.953978, "min": 0.552692}, "location": {"width": 688, "top": 840, "height": 28, "left": 70}, "words": "在一项服用7.5毫克地氯雷他定的单剂量研究中,食物(高脂肪、高热量早餐)对地氯留他定的代谢"}, {"probability": {"variance": 0, "average": 0.999418, "min": 0.998416}, "location": {"width": 65, "top": 864, "height": 16, "left": 37}, "words": "没有影响"}, {"probability": {"variance": 0.000398, "average": 0.988096, "min": 0.927926}, "location": {"width": 236, "top": 884, "height": 20, "left": 44}, "words": "【贮藏】密封,置干燥处保存"}, {"probability": {"variance": 0.025399, "average": 0.909155, "min": 0.496707}, "location": {"width": 294, "top": 905, "height": 22, "left": 43}, "words": "【包装】铝塑包装,12片/板×1/盒"}, {"probability": {"variance": 0.027561, "average": 0.938538, "min": 0.469036}, "location": {"width": 145, "top": 928, "height": 20, "left": 43}, "words": "【有效期】24个月"}, {"probability": {"variance": 0.006644, "average": 0.958242, "min": 0.726298}, "location": {"width": 282, "top": 951, "height": 19, "left": 43}, "words": "【执行标准】药品标准编号YBH07352010"}, {"probability": {"variance": 0.000245, "average": 0.989466, "min": 0.940712}, "location": {"width": 235, "top": 973, "height": 20, "left": 43}, "words": "【批准文号】国药准字H20103782"}, {"probability": {"variance": 0.000259, "average": 0.990935, "min": 0.955381}, "location": {"width": 87, "top": 995, "height": 18, "left": 42}, "words": "【生产企业】"}, {"probability": {"variance": 0.000914, "average": 0.989871, "min": 0.878723}, "location": {"width": 240, "top": 1019, "height": 18, "left": 45}, "words": "企业名称:成都明日制药有限公司"}, {"probability": {"variance": 2.9e-05, "average": 0.99712, "min": 0.979384}, "location": {"width": 306, "top": 1020, "height": 25, "left": 387}, "words": "生产地址:成都经济技术开发区南翼新城区"}, {"probability": {"variance": 0.000178, "average": 0.989375, "min": 0.950252}, "location": {"width": 131, "top": 1040, "height": 19, "left": 43}, "words": "邮政编码:610100"}, {"probability": {"variance": 0.002025, "average": 0.980804, "min": 0.76981}, "location": {"width": 323, "top": 1044, "height": 19, "left": 388}, "words": "电话号码:028-884323518843100087772858"}, {"probability": {"variance": 0.005708, "average": 0.980949, "min": 0.613899}, "location": {"width": 251, "top": 1062, "height": 19, "left": 43}, "words": "传真号码:028~8774691388432357"}, {"probability": {"variance": 0.022879, "average": 0.887976, "min": 0.492282}, "location": {"width": 223, "top": 1066, "height": 24, "left": 388}, "words": "网址:http:// WWW.try.cn"}], "language": -1}